Patent ID: 8394849

Claim:
A method of treating a Human papillomavirus (HPV)-induced condition in a human subject, wherein the condition is selected from the group consisting of oropharyngeal cancer, laryngeal cancer and esophageal cancer, the method comprising: identifying a subject with an HPV-postive oropharyngeal cancer, laryngeal cancer or esophageal cancer, and administering a therapeutically effective amount of an artemisinin-related compound to the identified subject, wherein the artemisinin-related compound is artemisinin, dihydroartemisinin, artemether, arteether, artesunate, artelinic acid, dihydroartemisinin propyl carbonate, or any combination thereof, and wherein the artemisinin-related compound is administered to the identified human subject by oral administration, topical administration, parenteral administration, systemic administration, intramuscular administration, or intravenous administration.